YOU ARE
A STUDY COORDINATOR
Success is when the time to access an innovative treatment is reduced.
CT-SCOUT Solution ToTem4me Solution
Save time in your research activity
Thanks to CT-SCOUTTM you can identify the studies running at your site that could be worth considering for a patient. No need to know or remember all studies criteria: CT-SCOUTTM powerful algorithm will efficiently support you in identifying the potential appropriate studies. CT-SCOUTTM can also help you coordinate the research activities with your colleagues
The CT-SCOUT app
Our web and mobile application exclusively designed for investigators, with its easy-to-use questionnaire.
Why CT-SCOUT app ?
Free up your time
Minimize the administrative burden and redundancy that keeps you and your site staff from focusing on clinical research and patient care.
Involve more patients
Help your patients expand access to clinical trials by integrating CT-SCOUT
Stay Connected
Receive alerts when a patient is identified and track your patients in a decentralized manner
Testimonials
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
« CT-SCOUT™ represents a true added value to clinical research. It takes only few minutes to operate and study information is updated very quickly »
« CT-SCOUT™ is important for patients because it facilitates their enrolment in clinical trials. Before CT-SCOUT™ we missed out on a lot of patients and now we have dramatically increased accrual in our studies. We communicate on it and this has clearly increased our visibility at national and international levels » ECCO Congress Prof Laurent Peyrin-Biroulet,
LATEST NEWSOUR NEWS >
May 22, 2023
Wednesday may 24 TELEMEDICINE TECHNOLOGIES will be present at SantExpo on the OVHcloud stand as a partner of the “Open Trusted Cloud” program. Our president Yoani Matsakis will be representing Telemedicine Technologies, and wil intervene next to Mathieu Godart, CTO and co-founder of SÊMEIA and Emmanuel MEYRIEUX, Client Security manager at OVHcloud. Throughout the day you […]
May 22, 2023
Fierce Biotech The FDA seems to be satisfied that Pfizer’s RSV vaccine is safe and effective for administration in pregnant women to protect infants from severe disease. The agency’s confidence was revealed in briefing documents filed ahead of an advisory committee meeting set for Thursday. The Vaccines and Related Biological Products Advisory Committee will consider […]
May 22, 2023
Trial Site News The World Health Organisation (WHO) decided Thursday May 4, 2023, to end the COVID-19 public health emergency of international concern (PHEIC). TrialSite cautions that this is a provisional (temporary) status while WHO considers its forward-looking options (2023-2025). Importantly, in “The COVID-19 Emergency is Over, Sort of,” TrialSite reports that in America some […]